Irreversible electroporation: A novel option for treatment of hepatic metastases

Current Colorectal Cancer Reports

Volumn 9, Issue 2, 2013, Pages 191-197

  Martin II, Robert C G ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Irreversible electroporation; Liver ablation; Metastatic colorectal cancer

Indexed keywords

FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

CANCER RECURRENCE; CANCER SURVIVAL; ELECTROPORATION; HISTOPATHOLOGY; HUMAN; LAPAROSCOPY; LAPAROTOMY; LIVER; LIVER METASTASIS; LOCAL RECURRENCE FREE SURVIVAL; METASTATIC COLORECTAL CANCER; RECURRENCE RISK; REVIEW;

EID: 84882811144     PISSN: 15563790     EISSN: 15563804     Source Type: Journal    
DOI: 10.1007/s11888-013-0166-5     Document Type: Review

References (30)

1. Bruix J, Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology. 2002;35:519-24.
2. Minami Y, Kudo M. Radiofrequency ablation of hepatocellular carcinoma: a literature review. Int J Hepatol. 2011;2011:104685.
3. Sindram D, Lau KN, Martinie JB, Iannitti DA. Hepatic tumor ablation. Surg Clin North Am. 2010;90:863-76.
4. Livraghi T, Goldberg SN, Lazzaroni S, Meloni F, Solbiati L, Gazelle GS. Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection. Radiology. 1999;210:655-61.
5. Shiina S, Tagawa K, Unuma T, Takanashi R, Yoshiura K, Komatsu Y, et al. Percutaneous ethanol injection therapy for hepatocellular carcinoma. A histopathologic study. Cancer. 1991;68:1524-30.
6. Vogl TJ, Mack MG, Muller PK, Straub R, Engelmann K, Eichler K. Interventional MR: interstitial therapy. Eur Radiol. 1999;9:1479-87.
7. Christophi C, Muralidharan V. Treatment of hepatocellular carcinoma by percutaneous laser hyperthermia. J Gastroenterol Hepatol. 2001;16:548-52.
8. Vogl TJ, Eichler K, Straub R, Engelmann K, Zangos S, Woitaschek D, et al. Laser-induced thermotherapy of malignant liver tumors: general principals, equipment(s), procedure(s) - side effects, complications and results. Eur J Ultrasound. 2001;13:117-27.
9. Ravikumar TS, Steele Jr GD. Hepatic cryosurgery. Surg Clin North Am. 1989;69:433-40.
10. Shen HP, Gong JP, Zuo GQ. Role of high-intensity focused ultrasound in treatment of hepatocellular carcinoma. Am Surg. 2011;77:1496-501.
11. Shibata T, Niinobu T, Ogata N, Takami M. Microwave coagulation therapy for multiple hepatic metastases from colorectal carcinoma. Cancer. 2000;89:276-84.
12. Yu NC, Lu DS, Raman SS, Dupuy DE, Simon CJ, Lassman C, et al. Hepatocellular carcinoma: microwave ablation with multiple straight and loop antenna clusters-pilot comparison with pathologic findings. Radiology. 2006;239:269-75.
13. O'Connor JK, Trotter J, Davis GL, Dempster J, Klintmalm GB, Goldstein RM. Long-term outcomes of stereotactic body radiation therapy in the treatment of hepatocellular cancer as a bridge to transplantation. Liver Transpl. 2012;18:949-54. This is one of the largest studies to report on stereotactic (intensity-modulated) radiation therapy, similar to CyberKnife therapy in the case of hepatic tumors.
14. Lu MD, Xu HX, Xie XY, Yin XY, Chen JW, Kuang M, et al. Percutaneous microwave and radiofrequency ablation for hepatocellular carcinoma: a retrospective comparative study. J Gastroenterol. 2005;40:1054-60.
15. Komorizono Y, Oketani M, Sako K, Yamasaki N, Shibatou T, Maeda M, et al. Risk factors for local recurrence of small hepatocellular carcinoma tumors after a single session, single application of percutaneous radiofrequency ablation. Cancer. 2003;97:1253-62.
16. Kim SW, Rhim H, Park M, Kim H, Kim YS, Choi D, et al. Percutaneous radiofrequency ablation of hepatocellular carcinomas adjacent to the gallbladder with internally cooled electrodes: assessment of safety and therapeutic efficacy. Korean J Radiol. 2009;10:366-76.
17. Lim DH, Lee H, Park HC, Lee JA, Kim SW, Yoo BC, et al. The efficacy of high-dose 3-dimensional conformal radiation therapy in patients with small hepatocellular carcinoma not eligible for other local modalities. Am J Clin Oncol. 2012;1024:1024. doi: 10.1097/COC.0b013e3182438dae.
18. Krishnan S, Lin EH, Gunn GB, Chandra A, Beddar AS, Briere TM, et al. Conformal radiotherapy of the dominant liver metastasis: a viable strategy for treatment of unresectable chemotherapy refractory colorectal cancer liver metastases. Am J Clin Oncol. 2006;29:562-7.
19. Lee RC. Cell injury by electric forces. Ann N Y Acad Sci. 2005;1066:85-91.
20. Bower M, Sherwood L, Li Y, Martin R. Irreversible electroporation of the pancreas: definitive local therapy without systemic effects. J Surg Oncol. 2011;104:22-8. This is the first report to demonstrate the safety of the use of IRE around vital blood vessels.
21. Maor E, Ivorra A, Leor J, Rubinsky B. The effect of irreversible electroporation on blood vessels. Technol Cancer Res Treat. 2007;6:307-12.
22. Guo Y, Zhang Y, Klein R, Nijm GM, Sahakian AV, Omary RA, et al. Irreversible electroporation therapy in the liver: longitudinal efficacy studies in a rat model of hepatocellular carcinoma. Cancer Res. 2010;70:1555-63. This article is an additional report on the safety of IRE in the liver in an in vivo model.
23. Charpentier KP, Wolf F, Noble L, Winn B, Resnick M, Dupuy DE. Irreversible electroporation of the liver and liver hilum in swine. HPB. 2011;13:168-73.
24. Charpentier KP, Wolf F, Noble L, Winn B, Resnick M, Dupuy DE. Irreversible electroporation of the pancreas in swine: a pilot study. HPB. 2010;12:348-51.
25. Martin 2nd RC, McFarland K, Ellis S, Velanovich V. Irreversible electroporation therapy in the management of locally advanced pancreatic adenocarcinoma. J Am Coll Surg. 2012;215:361-9.
26. Martin 2nd RC, McFarland K, Ellis S, Velanovich V. Irreversible electroporation in locally advanced pancreatic cancer: potential improved overall survival. Ann Surg Oncol. 2012;2424:2424. doi: 10.1245/s10434-012-2736- 1.
27. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer. 2009;45:228-47.
28. Niessen C, Jung EM, Stroszczynski C, Wiggermann P. Ablation einer Lebermetastase mit irreversibler Elektroporation (IRE) im Lebersegment II angrenzend an die Area nuda [Ablation of a liver metastasis with irreversible electroporation (IRE) in liver segment II adjoining the area nuda]. Rofo. 2012;184:937-8.
29. Cannon R, Ellis S, Hayes D, Narayanan G, Martin 2nd RC. Safety and early efficacy of irreversible electroporation for hepatic tumors in proximity to vital structures. J Surg Oncol. 2012;2424:2424. doi: 10.1002/jso.23280. This is the largest study of the use of IRE for ablation of hepatic tumors close to vital structures with long-term 12-month follow-up.
30. Thomson KR, Cheung W, Ellis SJ, Federman D, Kavnoudias H, Loader-Oliver D, et al. Investigation of the safety of irreversible electroporation in humans. J Vasc Interv Radiol. 2011;22:611-21.